Plain-English translation of NCT07609030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a structured online brain training program—called I-CAN—can help protect your thinking and memory during CAR-T cell therapy. CAR-T is a type of cellular immunotherapy used to treat certain blood cancers like multiple myeloma and non-Hodgkin lymphoma. The study will enroll 90 patients and track whether this medication can cause thinking problems, and whether the brain training helps prevent or reduce those problems.
Some patients receiving this treatment experience thinking or memory difficulties as a side effect. Researchers want to see if a targeted brain training program can help preserve cognitive function or help the brain recover better during and after treatment.
You likely qualify if…
You likely don't qualify if…
You would participate in online brain training sessions for about 2.5 hours per week for 4 weeks before you start your CAR-T treatment, and then again for 4 weeks after treatment begins (20 hours total over 8 weeks). During this time, you'll also have blood samples collected at multiple visits so researchers can study how the treatment affects your body at a cellular level. The study tracks your thinking skills, mood, physical strength, and overall well-being at several time points.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States